FDA Inspection 1148287 — CAIRE DIAGNOSTICS INC

CAIRE DIAGNOSTICS INC — FEI 3013216353

The FDA completed an inspection of CAIRE DIAGNOSTICS INC on August 3, 2021 in Pleasanton, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 3, 2021
Fiscal Year
2021
Product Type
Devices
Project Area
Compliance: Devices
Location
Pleasanton, CA (United States)

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
313021 CFR 820.100(a)Lack of or inadequate procedures
317221 CFR 820.198(c)Investigation of device failures
50221 CFR 820.60Identification procedures, Lack of or inadequate procedures